目錄:MedChemExpress LLC>>生化試劑>> Adalimumab (anti-TNF-α) | MCE
CAS | 331731-18-1 | 純度 | 99.62% |
---|---|---|---|
供貨周期 | 現貨 | 規格 | 10 mg |
貨號 | HY-P9908A | 應用領域 | 醫療衛生,化工,生物產業,制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 331731-18-1
產品活性:Adalimumab (anti-TNF-α) is a human monoclonal IgG1 antibody targeting tumour necrosis factor?α (TNF-α).
研究領域:Apoptosis
作用靶點:TNF Receptor
In Vitro: Treatment of HUVECs with Adalimumab for up to 12 hours shows no adverse effect on their cell viability, even with a 10-fold higher concentration of Adalimumab (anti-TNF-α) than used in this study.
In Vivo: The elimination half-life (t1/2) of Adalimumab (anti-TNF-α) is long (~20 days). The enriched fluorescent-labelled adalimumab (anti-TNF-α) is observed mainly in major Oil red O-positive lesions documenting good tissue penetration of the drug into the atherosclerotic plaque, without background fluorescence of the vessel wall after vehicle control injection into hypercholesterolemic Ldlr-/- mice.
相關產品:Relfovetmab | Anti-Mouse TNF alpha Antibody | Apremilast | QNZ | Broussonin E | Undecane | Utomilumab | 1,4-Dicaffeoylquinic acid | Asunercept | Cetrelimab | Mulberroside A | Ginsenoside Rc | (Rac)-BIO8898 | Dordaviprone | IW927 | Apratastat | Anti-inflammatory agent 16 | Sinulatumolin C | VGX-1027 | BMS-751324 | Koaburaside | Loganic acid 6′-O-β-D-glucoside | HS-276 | DCVC | Lucatumumab | Letolizumab | Licaminlimab | C25-140 | Roquinimex | HDMAPP triammonium
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業技術服務;
• 設有專業的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。